Home / Balsm Alofoq Medical Co. / 2025 Annual Results

Balsm Alofoq Medical Co. 2025 Annual Results

Revenue

SAR 20M

Net Profit

SAR 2M

EPS

SAR 0.79

Operating Cash Flow

SAR 3M

Balsm Alofoq Medical Co. (9620) reported full year 2025 revenue of SAR 20M, up 2.6% from SAR 20M in 2024. Net profit came in at SAR 2M, down 58.8% year on year. Earnings per share were SAR 0.79. The company generated SAR 3M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.50 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.50.

Key Financial Metrics

Metric	2025	2024
Revenue	SAR 20M	SAR 20M
Net Profit	SAR 2M	SAR 5M
Net Margin	9.7%	24.1%
ROE	6.4%	16.5%
EPS	SAR 0.79	SAR 4.68
Total Assets	SAR 36M	SAR 33M
Total Equity	SAR 31M	SAR 29M
Total Liabilities	SAR 5M	SAR 4M
Operating Cash Flow	SAR 3M	SAR 5M

Year on Year Comparison

Revenue increased by 2.6% compared to 2024. Net profit decreased by 58.8%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2025 2024

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-04-07.